Approval · Notice of Compliance 7615 · 2005
APTIVUS: Notice of Compliance 7615
Issued November 21, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7615
- Date
- November 21, 2005
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Non-peptidic protease inhibitor (nppi)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APTIVUS | 02273322 | Cancelled Post Market |
Medicinal ingredients
- TIPRANAVIR 250 MG per CAP